Wang Lulu, Jiang Jiankui, Sun Guisen, Zhang Panpan, Li Ya
Department of Spinal Surgery, ShengLi Oilfield Central Hospital, Dongying, Shandong 257000, P.R. China.
Department of Hand and Foot Surgery, ShengLi Oilfield Central Hospital, Dongying, Shandong 257000, P.R. China.
Oncol Lett. 2020 Nov;20(5):133. doi: 10.3892/ol.2020.11994. Epub 2020 Aug 20.
The present study aimed at investigating how long-chain non-coding RNA (lncRNA) tumor suppressor candidate 7 (TUSC7) regulates the malignant biological behavior of osteosarcoma cells. Tumor tissues and adjacent tissues of 30 patients with osteosarcoma were collected, and the expression levels of lncRNA TUSC7 and miR-375 were detected by RT-qPCR. lncRNA TUSC7 mimic and miR-375 mimic transfection models were established in MG63 osteosarcoma cells, and Transwell assays were used to detect the migration ability of MG63 cells. An MTT assay was used to assess the proliferation ability of MG63 cells. lncRNA TUSC7 in osteosarcoma tissue was significantly lower than that of adjacent tissues, while miR-375 levels were significantly higher than that of adjacent tissues; the two levels have a negative correlation. lncRNA TUSC7 mimic inhibited MG63 proliferation and migration abilities. miR-375 mimic promoted MG63 proliferation and migration abilities. The lncRNA TUSC7 mimic and miR-375 mimic co-transfection system could partially rescue the inhibition of lncRNA TUSC7 mimic on MG63 cells. In conclusion, lncRNA TUSC7 inhibited the proliferation and migration of MG63 osteosarcoma cells by regulating miR-375.
本研究旨在探讨长链非编码RNA(lncRNA)肿瘤抑制候选因子7(TUSC7)如何调节骨肉瘤细胞的恶性生物学行为。收集30例骨肉瘤患者的肿瘤组织及癌旁组织,采用RT-qPCR检测lncRNA TUSC7和miR-375的表达水平。在MG63骨肉瘤细胞中建立lncRNA TUSC7模拟物和miR-375模拟物转染模型,采用Transwell实验检测MG63细胞的迁移能力。采用MTT实验评估MG63细胞的增殖能力。骨肉瘤组织中lncRNA TUSC7明显低于癌旁组织,而miR-375水平明显高于癌旁组织;二者水平呈负相关。lncRNA TUSC7模拟物抑制MG63细胞的增殖和迁移能力。miR-375模拟物促进MG63细胞的增殖和迁移能力。lncRNA TUSC7模拟物和miR-375模拟物共转染系统可部分挽救lncRNA TUSC7模拟物对MG63细胞的抑制作用。综上所述,lncRNA TUSC7通过调节miR-375抑制MG63骨肉瘤细胞的增殖和迁移。